Key result
Conduction velocity was significantly lower in strands composed purely of stem cell-derived cardiomyocytes (5.5 cm/s) compared to primary cardiomyocytes (34.9 cm/s), leading to slow and heterogeneous conduction in mixed cultures.
Why the study?
Does the proportion of stem cell-derived cardiomyocytes affect conduction velocity in co-cultured strands with primary cardiomyocytes?
Does the proportion of stem cell-derived cardiomyocytes affect conduction velocity in co-cultured strands with primary cardiomyocytes?
In cultures of murine ventricular cardiomyocytes, stem cell-derived cardiomyocytes cannot restore conduction velocity to control levels, resulting in slow conduction that may lead to reentry circuits and arrhythmias.
May increase arrhythmia risk in stem cell therapies; leaves open whether optimized ratios normalize conduction in vivo.
Modern concepts for the treatment of myocardial diseases focus on novel cell therapeutic strategies involving stem cell-derived cardiomyocytes (SCMs). However, functional integration of SCMs requires similar electrophysiological properties as primary cardiomyocytes (PCMs) and the ability to establish intercellular connections with host myocytes in order to contribute to the electrical and mechanical activity of the heart. The aim of this project was to investigate the properties of cardiac conduction in a co-culture approach using SCMs and PCMs in cultured cell strands. Murine embryonic SCMs were pooled with fetal ventricular cells and seeded in predefined proportions on microelectrode arrays to form patterned strands of mixed cells. Conduction velocity (CV) was measured during steady state pacing. SCM excitability was estimated from action potentials measured in single cells using the patch clamp technique. Experiments were complemented with computer simulations of conduction using a detailed model of cellular architecture in mixed cell strands. CV was significantly lower in strands composed purely of SCMs (5.5 ± 1.5 cm/s, n = 11) as compared to PCMs (34.9 ± 2.9 cm/s, n = 21) at similar refractoriness (100% SCMs: 122 ± 25 ms, n = 9; 100% PCMs: 139 ± 67 ms, n = 14). In mixed strands combining both cell types, CV was higher than in pure SCMs strands, but always lower than in 100% PCM strands. Computer simulations demonstrated that both intercellular coupling and electrical excitability limit CV. These data provide evidence that in cultures of murine ventricular cardiomyocytes, SCMs cannot restore CV to control levels resulting in slow conduction, which may lead to reentry circuits and arrhythmias.
No takes yet. Share an insight, caveat, or question.
Kučera et al. (2015) studied Cardiac conduction in cell grafts. Stem cell-derived cardiomyocytes (SCMs) vs. Primary cardiomyocytes (PCMs) was evaluated on Conduction velocity (cm/s) (p=<0.05). Conduction velocity was significantly lower in strands composed purely of stem cell-derived cardiomyocytes (5.5 cm/s) compared to primary cardiomyocytes (34.9 cm/s), leading to slow and heterogeneous conduction in mixed cultures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: